Macrogenics Inc
MGNX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001125345
In the last 90 days, Macrogenics Inc insiders filed 0 open-market purchases and 1 sale; 122 institutions reported holding it in 13F filings for Q2 2026, worth $224.9M in total; no superinvestor holds it.
Q4 2024 vs. Q3 2024
How the institutions holding Macrogenics Inc changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Q4 2024 | Change |
|---|---|---|---|
| Holders | 124 | 129 | +5 |
| Shares | 55.8M | 56.1M | +389.4K (+0.7%) |
| Value | $187.9M | $182.5M | −$5.41M (−2.9%) |
New holders (23)
Institutions that held Macrogenics Inc at the end of Q4 2024 but not at the end of Q3 2024.
Sold out (18)
Institutions that held Macrogenics Inc at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Franklin Resources Inc | 107,293 | $459.2K |
| D. E. Shaw & Co., Inc. | 119,029 | $391.6K |
| Verition Fund Management LLC | 90,304 | $297.1K |
| Voloridge Investment Management, LLC | 72,879 | $239.8K |
| EcoR1 Capital, LLC | 56,018 | $184.3K |
| Brevan Howard Capital Management LP | 41,706 | $137.2K |
| Massachusetts Financial Services Co | 40,754 | $134.1K |
| Squarepoint Ops LLC | 37,170 | $122.3K |
| State of Wisconsin Investment Board | 32,775 | $107.8K |
| Simplex Trading, LLC | 29,615 | $97.0K |
| EntryPoint Capital, LLC | 28,173 | $92.7K |
| Virtus ETF Advisers LLC | 19,694 | $64.8K |
| Northeast Financial Consultants Inc | 10,000 | $32.9K |
| Jefferies Financial Group Inc. | 3,135 | $10.3K |
| Capital Performance Advisors LLP | 1,462 | $4.81K |
| Picton Mahoney Asset Management | 639 | $2.00K |
| True Wealth Design, LLC | 327 | $1.08K |
| GAMMA Investing LLC | 190 | $625 |